Saliva is an easily accessible source of high molecular weight DNA for Oxford Nanopore long-read sequencing applications.
Nurix advances CLL therapy with NX-5948 showing 83% response, 22.1-month PFS, $680M cash, and $3B risk-adjusted sales ...
Morning Overview on MSN
Plants hijack bacterial-style gene to make drugs, opening green pharma future
Plants are quietly borrowing tricks from bacteria, repurposing foreign genes to build complex molecules that look a lot like ...
A research team led by Zhiping Weng, Ph.D., and Jill Moore, Ph.D."18, at UMass Chan Medical School, has nearly tripled the ...
Financing led by institutional investors, with participation from new investor Eli Lilly and CompanyInclusive of this ...
Phase 1 study of REX-8756 is well underway following FDA clearance of the Investigational New Drug (IND) application in December 2025--In ...
Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...
Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for ...
Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced the expansion of its Scientific Advisory ...
This important study introduces a new biology-informed strategy for deep learning models aiming to predict mutational effects in antibody sequences. It provides solid evidence that separating ...
Add Yahoo as a preferred source to see more of our stories on Google. mosquito silhouette From missing dinosaur feathers to fictitious pack-hunting behaviors, many details of the Jurassic Park movie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback